InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
60,685.94
(
0.02%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

LaddyMan

Send PM Follow Ignore
Followers 48
Posts 2777
Boards Moderated 0
Alias Born 05/25/2012

LaddyMan

Re: None

Thursday, 08/06/2015 4:08:20 PM

Thursday, August 06, 2015 4:08:20 PM

Post# of 158400
"Entest's Zander unit recently licensed IP from Regen BioPharma Inc. that will allow the Company to develop both novel, first-in- class, "smart" drugs for veterinary therapies as well as immune- oncology drugs. Zander will also strive to identify co-development opportunities which would lead to fast tracking drug development.

Entest BioMedical is a developer of veterinary medicines that harness the animal's own reparative / immunological mechanisms."


Stands to benefit the whole family.... GO little brother...go!

BMSN
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up